At Komen, we’re committed to saving lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancers. As a result, we’ve provided grants that have contributed to significant advances in the breast cancer arena for 40 years. Beginning in 1982, with a single research grant for $28,000, our research investments are nearly $1.1 billion, funding more than 2700 research grants and over 550 clinical trials. We’re proud to have funded research in the U.S. and 24 other countries around the world, covering the spectrum of breast cancer– from basic cancer cell biology to risk reduction, early detection and diagnosis to new treatments and improved quality of life.
We have also provided $2.3 billion in grants to organizations that operate in local communities. All told, we have invested more than $3.3 billion in grants and programs that have supported research, screening, education, treatment and psychosocial support for breast cancer.
Types of Grants We Fund
To learn more about specific types of grants, follow the links below.
For an easy-to-understand, layperson’s description of our research and scientific programs, as well as more details on who we support, our research dollars at work and stories about our researchers, visit the We Fund Research page in the What We Do section of our website.
The Decision-Making Process
Learn more about how Komen selects which grants will be supported.
Dr. Elizabeth McDonald, Clinician Researcher
“In my research studies, I think of how the results will impact the patients I see and serve in the clinic. With Komen funding, we have the opportunity to change lives.”
Those Who Guide Our Decisions
Learn more about the distinguished people who help advise us.
Scientific Advisory Board
Our Scientific Advisory Board provides strategic guidance and direction for our grantmaking programs.
The Komen Scholars are an international advisory group of distinguished leaders in breast cancer research and advocacy. They lend their expertise to our peer review process to help us select the best science and make the greatest impact on breast cancer.
Advocates in Science Steering Committee
The Advocates in Science Steering Committee is comprised of seven experienced advocates who work closely with Komen staff to develop training for other research and patient advocates and actively engage our advisory boards in the benefits and outcomes of effective research advocacy.